Gary Valaskovic

Gary Valaskovic

Research Fellow and Co-Founder

Gary Valaskovic (Ph.D.) is a distinguished entrepreneur and co-founder, together with Emily Ehrenfeld, of New Objective. He served as its CEO from 1997 to 2016. He has lead the successful design and manufacturing of innovative microfluidic and mass spectrometry technologies for ultra-high sensitivity measurement in the life sciences. Dr. Valaskovic is the author of more than 20 peer-reviewed publications, and currently holds more than 12 international patents focusing on improving electrospray mass spectrometry, capillary separations, and microfluidics. In 2013, along with Mike Lee, Emily Ehrenfeld and Robert Kennedy he co-founded Mozaic Solutions, a microfluidics company focusing on segmented flow technology.

Dr. Valaskovic’s formal scientific training began under the mentorship of the late Dr. Walter C. McCrone, an internationally recognized leader in the application of polarized light microscopy. He received his B.S. degree in Chemistry from the University of Illinois and his Ph.D. in analytical chemistry from Cornell University under the late Prof. George H. Morrison. His journey into the application of mass spectrometry to the life sciences continued with post-doctoral research in the group of Prof. Fred W. McLafferty at Cornell. He currently holds the position of Research Fellow, continuing his long record of innovation. Current research interests include applied microfluidics, novel interface technologies for mass spectrometry, and the translation of such technology to the clinical setting.